Company: AMKR
Filing Date: 2025-10-28
Form Type: 10-Q
Source: 0001047127-25-000190
Chunk: 214

Company: AMKOR TECHNOLOGY, INC.
Filing Date: 2025-10-28
Form: 10-Q
Item: Part I, Item 2
Chunk 214
---
. 

Our net sales, gross profit, operating income, cash flows, liquidity and capital resources have historically fluctuated significantly from quarter to quarter due to many factors, including the seasonality of our business, the cyclical nature of the semiconductor industry and other factors discussed in the “Risk Factors” section in Part II, Item 1A of this Form 10-Q.  We continue to monitor the recent changes in global trade policy, including tariffs and related trade actions announced by the U.S. and other countries.  The degree to which such tariffs and other related actions impact our business, financial condition and results of operations will depend on future developments, which are uncertain.  We will continue to make prudent investments, and we will closely manage capacity expansion and control costs in response to any changes in market conditions.

Financial Summary

Our net sales increased $125.4 million, or 6.7%, to $1,987.0 million for the three months ended September 30, 2025 compared to $1,861.6 million for the three months ended September 30, 2024, primarily due to growth in our computing and communications end markets.

Gross margin for the three months ended September 30, 2025 decreased to 14.3% compared to 14.6% for the three months ended September 30, 2024.  The decrease in gross margin was primarily due to increased overhead and employee compensation costs, partially offset by a decrease in the proportion of products sold with higher material content and higher factory utilization driven by the increase in net sales.

Operating income margin remained consistent at 8.0% for the three months ended September 30, 2025 and the three months ended September 30, 2024. 

Our capital expenditures totaled $472.5 million for the nine months ended September 30, 2025 compared to $458.1 million for the nine months ended September 30, 2024.  Our spending was primarily focused on investments in advanced packaging and test equipment. 

Net cash provided by operating activities was $451.1 million for the nine months ended September 30, 2025 compared to $551.3 million for the nine months ended September 30, 2024.  This decrease was primarily due to changes in working capital and lower operating profits.

-26-

Results of Operations

The following table sets forth certain operating data as a percentage of net sales for the periods indicated:

For the Three Months Ended September 30,